Exploring Ketamine: The Facts Behind the Hype

Join us for an eye-opening panel discussion where we’ll explore how KAP (ketamine-assisted psychotherapy) is transforming the way we treat depression, anxiety, and PTSD. This isn’t just about theory; you’ll get a front-row seat to the real science, practical applications, and personal stories behind this cutting-edge therapy.

We’re also excited to feature a real-life experience from someone who has undergone KAP. They’ll share what it felt like, the impact on their life, and tips for those curious about this innovative therapy.

Why attend? Whether you’re a mental health professional, a person exploring new treatment options, or just fascinated by new developments in therapy, this event will deepen your understanding of KAP. You’ll leave with practical knowledge and a fresh perspective on how this therapy could make a difference.

Join us for an enlightening and inspiring discussion!

Panelist:

SANDHYA PRASHAD, MD

Sandhya Prashad, MD is a board-certified psychiatrist specializing in interventional modalities for treatment resistant disorders with a particular interest and expertise in ketamine therapy. She completed both medical school and psychiatry residency at Baylor College of Medicine. She has been in private practice in the Houston area since 2011 and has been utilizing intravenous ketamine since 2016. She has personally administered over 9,000 treatments with ketamine or esketamine. She is the founder and medical director of Sandhya J. Prashad, MD, Houston Ketamine Therapeutics, and Houston TMS Therapeutics. Dr. Prashad is involved on an international level with furthering awareness and education regarding the safe and effective use of ketamine. She is a founder, the former secretary and the current president of the American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3, www.ASKP.org) Dr. Prashad presents frequently on a national level both to the public and to other physicians regarding the use of ketamine for psychiatric disorders. She also serves on several advisory panels for ketamine related research. She is also a faculty member of the Integrative Psychiatry Institute where she assisted in developing the curriculum for the ketamine medical provider training. She also actively lectures and mentors others through the program, which was designed to establish the gold standard in ketamine competency for healthcare providers. Dr. Prashad has been appointed as a clinical assistant professor at Baylor College of Medicine in the Menninger Department of Psychiatry and Behavioral Sciences where she assists in education of residents and medical students regarding the use of ketamine, esketamine and TMS in clinical practice. Dr. Prashad was also named one of Houston’s Top Doctors by H Texas Magazine for 2017, 2018, 2019 and 2020. She continues to work to expand her practice to include evidence based interventional treatments as they become available, and has a particular interest in expanding access to these treatments.

PsyT Disclaimer: Version January 2024

PsyT does not hold ceremonies or promote illegal activities during our events. This is not a place to seek, encourage, or participate in the procurement of controlled substances. You agree that you will not contact us for such things and will not engage in any such activities in your participation in any PsyT event. We provide a platform to discuss experiences that offer transformation in our personal and professional lives. You acknowledge that any information we provide is for educational purposes only and is not intended to be a substitute for medical advice, diagnosis, or treatment.

**Please do not use our space to promote or source substance and retreats**